Pharma companies worried as exports to Russia, Ukraine may get hit

The Russia-Ukraine crisis and sanctions against Russia by many western countries including the US may cause some damage to Indian pharmaceutical exports, executives of pharma industry told ET.

Drug industry executives are worried that sanctions against Russian banks may impact remittances of outstanding trade receivables from that country.

Western governments have warned of more sanctions should the crisis escalate.

Dr Reddy’s and Sun Pharma, which have significant front-end presence in both Russia and Ukraine, said they are closely monitoring the situation, adding that their primary focus at the moment is to ensure safety of employees.

“Ensuring the well-being of our staff is the first and foremost priority, along with meeting patient needs and business continuity,” said a spokesperson at Dr Reddy’s that has had a presence in the region for more than three decades. “We have been monitoring developments closely and preparing accordingly.”

India’s largest drug maker Sun Pharma, which has presence in both the countries, said it is “hoping for the best outcome”. “We are in constant touch with our employees in both countries and they are safe,” a company spokesperson said.

India had exported pharmaceuticals worth $591 million to Russia and worth $182 million to Ukraine in 2020-21, as per Pharmaceuticals Export Promotion Council (Pharmexcil) under the commerce department. Dinesh Dua, former chairman of Pharmexcil and CEO of Nectar Lifesciences, said the impact on pharmaceutical exports may not be huge. However, if the sanctions against Russia by the West escalate, then the industry may find it hard to do any business there, he said.

Indian drug makers had similar problems with Iran and Venezuela in the past. “In Iran we couldn’t transact business for a very long time,” Dua said. “Russia business may possibly become like that.”

Russia accounts for 2.4% of total pharmaceutical exports from the country while Ukraine has a share of 0.74%. India exported pharmaceuticals worth $24.5 billion in FY21. Revenues from Russia for Dr Reddy’s was about ₹1,580 crore, or 8.5% of its total revenues, in FY21. It is also among top 10 pharma companies in Ukraine.

  • Related Posts

    • Pharma
    • June 20, 2025
    • 146 views
    Key supplier in alprazolam smuggling racket arrested in Uttar Pradesh

    The prime accused in a racket involving the unauthorised sale of alprazolam tablets across Andhra Pradesh and Telangana was traced to Kanpur, Uttar Pradesh by the Telangana Prohibition and Excise…

    • Pharma
    • June 20, 2025
    • 124 views
    Cough Syrup Smuggling Ring Busted in Bihar’s Samastipur; Two Women Among Seven Arrested

    Samastipur:  Police in the district have arrested seven individuals, including two women, for allegedly smuggling nearly 1,000 bottles of banned cough syrup containing narcotic substances. The seizure, made during a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Key supplier in alprazolam smuggling racket arrested in Uttar Pradesh

    Key supplier in alprazolam smuggling racket arrested in Uttar Pradesh

    Cough Syrup Smuggling Ring Busted in Bihar’s Samastipur; Two Women Among Seven Arrested

    Cough Syrup Smuggling Ring Busted in Bihar’s Samastipur; Two Women Among Seven Arrested

    Counterfeit cholesterol drugs worth Rs 3 lakh seized in raids at Koti

    Counterfeit cholesterol drugs worth Rs 3 lakh seized in raids at Koti

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product